Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
Loureiro, Jesús
Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. [electronic resource] - PloS one 2013 - e61165 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0061165 doi
Animals
Epithelial-Mesenchymal Transition--drug effects
Female
Fibrinolysis--drug effects
Mice
Mice, Inbred C57BL
Neovascularization, Pathologic--drug therapy
Peritoneal Dialysis--adverse effects
Peritoneum--blood supply
Phenotype
Tamoxifen--pharmacology
Transforming Growth Factor beta1--pharmacology
Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. [electronic resource] - PloS one 2013 - e61165 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0061165 doi
Animals
Epithelial-Mesenchymal Transition--drug effects
Female
Fibrinolysis--drug effects
Mice
Mice, Inbred C57BL
Neovascularization, Pathologic--drug therapy
Peritoneal Dialysis--adverse effects
Peritoneum--blood supply
Phenotype
Tamoxifen--pharmacology
Transforming Growth Factor beta1--pharmacology